Exchange: NASDAQ·Updated 04:00 AM EDT
RNTX logo

RNTXRein Therapeutics, Inc. Common Stock

$1.05
$0.02
(1.94%)
Pre-Market
Prev Close $1.03
Mkt Cap$84.81M
Vol4.00
News
all
press releases
News Placeholder
All You Need to Know About Rein Therapeutics Inc. (RNTX) Rating Upgrade to Buy
Rein Therapeutics Inc. (RNTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
News Placeholder
Rein Therapeutics Inc. (NASDAQ:RNTX) Short Interest Down 51.4% in April
Rein Therapeutics Inc. (NASDAQ:RNTX - Get Free Report) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totaling 236,711...
MarketBeat
<
...
1
>

Advertisement|Remove ads.